Mylan Launches Lithium Carbonate ER 450mg

Mylan annnonced the launch of Lithium Carbonate Extended-Release Tablets 450mg, the generic version of Noven Therapeutic's Lithobid tablets.

Lithium Carbonate is indicated for the treatment of manic episodes of bipolar disorder and as maintenance treatment for individuals with a diagnosis of bipolar disorder. Lithium Carbonate is thought to exert its mood stabilizing effect by replacing sodium to inhibit voltage-sensitive sodium channels, causing stabilization of neuronal membranes.

Lithium Carbonate Extended-Release Tablets 450mg is being launched immediately.

For more information call (800) RX-MYLAN or visit www.mylan.com.